Dithiazanine Iodide

CHEMBL421701 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

518.5 g/mol

LogP

—

Phase

4

An iodide salt form of dithiazanine used to treat infections with intestinal parasites such as strongyloides and other worms. Like the parent compound, it disrupts parasite metabolism.

Berat Molekul

518,5000 g/mol

TPSA

60,70 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN1/C(=C/C=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-]

InChI

InChI=1S/C23H23N2S2.HI/c1-3-24-18-12-8-10-14-20(18)26-22(24)16-6-5-7-17-23-25(4-2)19-13-9-11-15-21(19)27-23;/h5-17H,3-4H2,1-2H3;1H/q+1;/p-1

Molecular Formula

C23H23IN2S2

HBD / HBA

- / 4

Ikatan yang Dapat Dirotasi

5

Atom Berat

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An iodide salt form of dithiazanine used to treat infections with intestinal parasites such as strongyloides and other worms. Like the parent compound, it disrupts parasite metabolism.

Yes, Dithiazanine Iodide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL421701. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5702697. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Dithiazanine Iodide di PillFYI

Struktur

Data Cepat

Rumus: C23H23IN2S2

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.